Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
FXIa Inhibitor by BioSeedin for Arterial Thrombosis: Likelihood of Approval
FXIa Inhibitor is under clinical development by BioSeedin and currently in Phase I for Arterial Thrombosis. According to GlobalData, Phase...
Data Insights
FXIa Inhibitor by BioSeedin for Deep Vein Thrombosis (DVT): Likelihood of Approval
FXIa Inhibitor is under clinical development by BioSeedin and currently in Phase I for Deep Vein Thrombosis (DVT). According to...